DK0759295T3 - Anvendelse af adamantan-derivater til behandling af tinnitus - Google Patents

Anvendelse af adamantan-derivater til behandling af tinnitus

Info

Publication number: DK0759295T3
Authority: DK; Denmark
Prior art keywords: adamantane derivatives; treat tinnitus; alkyl; tinnitus; treat
Prior art date: 1995-08-02

Application number

DK96112325T

Other languages

English (en)

Inventor

Hans Peter Prof Dr Med Zenner

J Peter Prof Dr Ruppersberg

Original Assignee

Tinnitus Forschungs Und Entwic

Hans Peter Prof Dr Med Zenner

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-02

Filing date

1996-07-31

Publication date

1999-01-25

1996-07-31 Application filed by Tinnitus Forschungs Und Entwic, Hans Peter Prof Dr Med Zenner filed Critical Tinnitus Forschungs Und Entwic

1999-01-25 Application granted granted Critical

1999-01-25 Publication of DK0759295T3 publication Critical patent/DK0759295T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK96112325T 1995-08-02 1996-07-31 Anvendelse af adamantan-derivater til behandling af tinnitus DK0759295T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19528388A DE19528388A1 (de)	1995-08-02	1995-08-02	Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs

Publications (1)

Publication Number	Publication Date
DK0759295T3 true DK0759295T3 (da)	1999-01-25

Family

ID=7768513

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96112325T DK0759295T3 (da)	1995-08-02	1996-07-31	Anvendelse af adamantan-derivater til behandling af tinnitus

Country Status (14)

Country	Link
US (1)	US6066652A (da)
EP (2)	EP0759295B1 (da)
JP (1)	JP3568039B2 (da)
KR (1)	KR100393296B1 (da)
CN (1)	CN1142775C (da)
AT (1)	ATE163545T1 (da)
AU (1)	AU719018B2 (da)
BR (1)	BR9609950A (da)
DE (3)	DE19528388A1 (da)
DK (1)	DK0759295T3 (da)
ES (1)	ES2116801T3 (da)
IL (1)	IL123142A (da)
PL (1)	PL324795A1 (da)
WO (1)	WO1997004762A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6649621B2 (en) *	1997-12-16	2003-11-18	The United States Of America As Represented By The Secretary Of The Navy	Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
US7132406B2 (en) *	1998-02-23	2006-11-07	Sound Pharmaceuticals Incorporated	Stimulation of cellular regeneration and differentiation in the inner ear
DE19807426A1 (de) *	1998-02-23	1999-10-14	Otogene Biotechnologische Fors	Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
WO2000072835A2 (en) *	1999-05-27	2000-12-07	El Khoury George F	Topical application of muscarinic and opioid agents for treatment of tinnitus
US6444702B1 (en)	2000-02-22	2002-09-03	Neuromolecular, Inc.	Aminoadamantane derivatives as therapeutic agents
US6689314B2 (en) *	2000-08-08	2004-02-10	International Paper Company	Process for activating oxygen scavenger components during a gable-top carton filling process
EP1201234A3 (en) *	2000-09-21	2003-03-12	Tinnitus Forschungs- und Entwicklungs GmbH	Treatment of diseases with adamantane derivates
EP1190709A1 (en) *	2000-09-21	2002-03-27	Tinnitus Forschungs- und Entwicklungs GmbH	Treatment of tinnitus
EP1190711A1 (en) *	2000-09-21	2002-03-27	Tinnitus Forschungs- und Entwicklungs GmbH	Treatment of diseases with adamantane derivatives
AU9424501A (en)	2000-10-13	2002-04-22	Chugai Pharmaceutical Co Ltd	Compositions for improving lipid metabolism
US20040122090A1 (en) *	2001-12-07	2004-06-24	Lipton Stuart A.	Methods for treating neuropsychiatric disorders with nmda receptor antagonists
US7795468B2 (en) *	2001-01-19	2010-09-14	Chevron U.S.A. Inc.	Functionalized higher diamondoids
WO2004096256A1 (en) *	2001-01-23	2004-11-11	The United States Of America, As Represented By The Secretary Of The Navy	Methods for preventing and treating loss of balance function due to oxidative stress
WO2004022069A1 (en) *	2002-09-06	2004-03-18	Durect Corporation	Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
US20060063802A1 (en) *	2004-03-29	2006-03-23	Matthieu Guitton	Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US9072662B2 (en)	2004-03-29	2015-07-07	Auris Medical Ag	Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) *	2004-03-29	2012-09-18	Matthieu Guitton	Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8349359B2 (en)	2004-11-07	2013-01-08	Your Energy Systems, LLC	Liposomal formulation for oral administration of glutathione (reduced)
US7619007B2 (en)	2004-11-23	2009-11-17	Adamas Pharmaceuticals, Inc.	Method and composition for administering an NMDA receptor antagonist to a subject
US20060211650A1 (en) *	2004-12-16	2006-09-21	Forest Laboratories, Inc.	Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
CA2594963A1 (en) *	2005-01-24	2006-07-27	Neurosystec Corporation	Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
DE102005004343A1 (de) *	2005-01-25	2006-08-10	Eberhard-Karls-Universität Tübingen Universitätsklinikum	Behandlung von Phantomphänomenen
JP2008531726A (ja) *	2005-03-04	2008-08-14	ニューロシステックコーポレイション	改良されたガシクリジン製剤
EP1874282B1 (en)	2005-04-06	2010-09-15	Adamas Pharmaceuticals, Inc.	Methods and compositions for treatment of cns disorders
WO2007012064A2 (en) *	2005-07-20	2007-01-25	Cypress Bioscience, Inc.	Prevention and treatment of hearing disorders
BRPI0520588B8 (pt)	2005-09-28	2021-05-25	Auris Medical Ag	uso de composições farmacêuticas para o tratamento de doenças do ouvido interno
US8267905B2 (en) *	2006-05-01	2012-09-18	Neurosystec Corporation	Apparatus and method for delivery of therapeutic and other types of agents
US7803148B2 (en) *	2006-06-09	2010-09-28	Neurosystec Corporation	Flow-induced delivery from a drug mass
JP2009544355A (ja) *	2006-07-20	2009-12-17	ニューロシステックコーポレイション	眼科薬物送達のためのデバイス、システム、および方法
EP2056793A4 (en) *	2006-07-31	2011-08-17	Neurosystec Corp	NANOPARTICLES WITH FREE BASE OF GACYCLIDINE
US20080065002A1 (en) *	2006-09-07	2008-03-13	Neurosystec Corporation	Catheter for Localized Drug Delivery and/or Electrical Stimulation
US20100129467A9 (en)	2007-08-31	2010-05-27	Albritton Iv Ford D	Nutritional supplement
EP2548552B1 (en) *	2007-09-12	2015-11-18	Merz Pharma GmbH & Co. KGaA	Titration package for 1-amino-alkylcyclohexanes
TW201010691A (en) *	2008-06-12	2010-03-16	Merz Pharma Gmbh & Co Kgaa	1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
US8454877B2 (en) *	2009-04-03	2013-06-04	Pelican Products, Inc.	Method and apparatus for molding an article
BR112012013487A2 (pt)	2009-12-02	2017-10-03	Adamas Pharmaceuticals Inc	Composições de amantadina e métodos de uso
US20110294890A1 (en) *	2010-05-28	2011-12-01	Merz Pharma Gmbh & Co. Kgaa	Neramexane for the treatment or prevention of inner ear disorders
WO2013087090A1 (en)	2011-12-12	2013-06-20	Auris Medical Ag	Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system
WO2014204933A1 (en)	2013-06-17	2014-12-24	Adamas Pharmaceuticals, Inc.	Amantadine compositions and methods of use
IL302486A (en)	2015-06-24	2023-06-01	Hoffmann La Roche	Antibodies against the transnephrine receptor with adapted affinity
AR106189A1 (es)	2015-10-02	2017-12-20	Hoffmann La Roche	ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
CN114057885A (zh)	2015-10-02	2022-02-18	豪夫迈·罗氏有限公司	双特异性抗人cd20/人转铁蛋白受体抗体及使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3328251A (en) *	1965-12-30	1967-06-27	Du Pont	Pharmaceutical compositions and methods utilizing 2-aminoadamantane and its derivatives
US4331686A (en) *	1981-08-28	1982-05-25	Pennwalt Corporation	Treatment of otitis externa in dogs with beta-(1-adamantyl)-alpha,alpha-dimethylethylamine
DE10299048I2 (de) *	1989-04-14	2006-07-13	Merz Pharma Gmbh & Co Kgaa	Verwendung von Adamantan-Derivaten zur Pr{vention und Behandlung der cerebralen Isch{mie
DE3921062A1 (de) *	1989-06-23	1991-01-03	Lange Werner	Therapie und prophylaxe von infektionen mit retroviren mit 1-adamantanamin hydrochlorid (amantadin) allein oder in kombination mit anderen antiviralen substanzen
DE4014672A1 (de) *	1990-05-08	1991-11-14	Werner E G Prof Dr Mueller	Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

1995
- 1995-08-02 DE DE19528388A patent/DE19528388A1/de not_active Withdrawn
1996
- 1996-07-31 KR KR10-1998-0700738A patent/KR100393296B1/ko not_active Expired - Fee Related
- 1996-07-31 DE DE19680619T patent/DE19680619D2/de not_active Expired - Lifetime
- 1996-07-31 US US09/011,085 patent/US6066652A/en not_active Expired - Lifetime
- 1996-07-31 EP EP96112325A patent/EP0759295B1/de not_active Expired - Lifetime
- 1996-07-31 BR BR9609950A patent/BR9609950A/pt not_active Application Discontinuation
- 1996-07-31 JP JP50725097A patent/JP3568039B2/ja not_active Expired - Fee Related
- 1996-07-31 ES ES96112325T patent/ES2116801T3/es not_active Expired - Lifetime
- 1996-07-31 WO PCT/EP1996/003360 patent/WO1997004762A1/de not_active Ceased
- 1996-07-31 PL PL96324795A patent/PL324795A1/xx unknown
- 1996-07-31 CN CNB961966505A patent/CN1142775C/zh not_active Expired - Fee Related
- 1996-07-31 AT AT96112325T patent/ATE163545T1/de active
- 1996-07-31 IL IL12314296A patent/IL123142A/en not_active IP Right Cessation
- 1996-07-31 DK DK96112325T patent/DK0759295T3/da active
- 1996-07-31 AU AU67882/96A patent/AU719018B2/en not_active Ceased
- 1996-07-31 EP EP97122113A patent/EP0834310A1/de not_active Withdrawn
- 1996-07-31 DE DE59600105T patent/DE59600105D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2000515486A (ja)	2000-11-21
AU719018B2 (en)	2000-05-04
CN1142775C (zh)	2004-03-24
IL123142A0 (en)	1998-09-24
US6066652A (en)	2000-05-23
IL123142A (en)	2001-10-31
WO1997004762A1 (de)	1997-02-13
EP0834310A1 (de)	1998-04-08
DE19528388A1 (de)	1997-02-06
CN1194581A (zh)	1998-09-30
ATE163545T1 (de)	1998-03-15
PL324795A1 (en)	1998-06-22
KR100393296B1 (ko)	2003-11-17
ES2116801T3 (es)	1998-07-16
DE19680619D2 (de)	1998-10-29
MX9800925A (es)	1998-10-31
JP3568039B2 (ja)	2004-09-22
AU6788296A (en)	1997-02-26
KR19990036073A (ko)	1999-05-25
BR9609950A (pt)	1999-06-29
EP0759295B1 (de)	1998-03-04
DE59600105D1 (de)	1998-04-09
EP0759295A1 (de)	1997-02-26

Publication	Publication Date	Title
DK0759295T3 (da)	1999-01-25	Anvendelse af adamantan-derivater til behandling af tinnitus
DE60037892D1 (de)	2008-03-13	Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
NZ332762A (en)	2000-09-29	Isobutylgaba and its derivatives for the treatment of pain
DE69615558D1 (de)	2001-10-31	Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen
ATE283268T1 (de)	2004-12-15	2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
NO305174B1 (no)	1999-04-12	Heterocykliske forbindelser
NO943521L (no)	1995-03-27	Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum
ATE70274T1 (de)	1991-12-15	Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
DK0604186T3 (da)	1997-06-16	HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DE69603667D1 (de)	1999-09-16	Indol-, Indazol- und Benzisoxazolderivate zur Behandlung von Schizophrenia
DK0787491T3 (da)	2000-10-16	Middel til forebyggelse og behandling af allergiske sygdomme af type I
ES2094545T3 (es)	1997-01-16	Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
DK1068184T3 (da)	2002-12-30	N-aryloxyethylaminderivater til behandling af despression
DE69708484D1 (de)	2002-01-10	Pyridinderivate,als Arzneimittel zur Behandlung von Geschwüren und als antibakterielle Mittel
CO5040091A1 (es)	2001-05-29	Derivados de urea
DE69619088D1 (de)	2002-03-21	Quinoxalin-Derivate zur Behandlung von Tinnitus
DE60005525D1 (de)	2003-10-30	2-aminotetraline zur behandlung von glaukom
DE69327077D1 (de)	1999-12-30	Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
DK0877612T3 (da)	2000-10-09	Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser
DK0766695T3 (da)	1999-02-15	Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme
DK0667860T3 (da)	1999-05-25	Azaspiroalkan-derivater som terapeutiske midler